Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Cancer Proliferation Gene Discovery Through Functional Genomics
Michael R. Schlabach,1*
Ji Luo,1*
Nicole L. Solimini,1*
Guang Hu,1*
Qikai Xu,1
Mamie Z. Li,1
Zhenming Zhao,1
Agata Smogorzewska,1,2
Mathew E. Sowa,3
Xiaolu L. Ang,3
Thomas F. Westbrook,1
Anthony C. Liang,1
Kenneth Chang,4
Jennifer A. Hackett,1
J. Wade Harper,3
Gregory J. Hannon,4
Stephen J. Elledge1
Abstract:
Retroviral short hairpin RNA (shRNA)–mediated geneticscreens in mammalian cells are powerful tools for discoveringloss-of-function phenotypes. We describe a highly parallel multiplexmethodology for screening large pools of shRNAs using half-hairpinbarcodes for microarray deconvolution. We carried out dropoutscreens for shRNAs that affect cell proliferation and viabilityin cancer cells and normal cells. We identified many shRNAsto be antiproliferative that target core cellular processes,such as the cell cycle and protein translation, in all cellsexamined. Moreover, we identified genes that are selectivelyrequired for proliferation and survival in different cell lines.Our platform enables rapid and cost-effective genome-wide screensto identify cancer proliferation and survival genes for targetdiscovery. Such efforts are complementary to the Cancer GenomeAtlas and provide an alternative functional view of cancer cells.
1 Howard Hughes Medical Institute and Department of Genetics, Center for Genetics and Genomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. 2 Department of Pathology, Massachusetts General Hospital (MGH), Boston, MA 02114, USA. 3 Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. 4 Watson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: selledge{at}genetics.med.harvard.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (5 February 2008) Sci. Signal.1 (5), ec50.
[DOI: 10.1126/stke.15ec50] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an E{mu}-myc/Bcl-2 mouse model.
J. R. Mills, A. Malina, T. Lee, D. Di Paola, O. Larsson, C. Miething, F. Grosse, H. Tang, M. Zannis-Hadjopoulos, S. W. Lowe, et al. (2013)
Blood
121, 3402-3412
|Abstract »|Full Text »|PDF »
Kinase-Substrate Enrichment Analysis Provides Insights into the Heterogeneity of Signaling Pathway Activation in Leukemia Cells.
P. Casado, J.-C. Rodriguez-Prados, S. C. Cosulich, S. Guichard, B. Vanhaesebroeck, S. Joel, and P. R. Cutillas (2013)
Science Signaling
6, rs6
|Abstract »|Full Text »|PDF »
Biomimetic, synthetic HDL nanostructures for lymphoma.
S. Yang, M. G. Damiano, H. Zhang, S. Tripathy, A. J. Luthi, J. S. Rink, A. V. Ugolkov, A. T. K. Singh, S. S. Dave, L. I. Gordon, et al. (2013)
PNAS
110, 2511-2516
|Abstract »|Full Text »|PDF »
STOP gene Phactr4 is a tumor suppressor.
N. L. Solimini, A. C. Liang, C. Xu, N. N. Pavlova, Q. Xu, T. Davoli, M. Z. Li, K.-K. Wong, and S. J. Elledge (2013)
PNAS
110, E407-E414
|Abstract »|Full Text »|PDF »
NetwoRx: connecting drugs to networks and phenotypes in Saccharomyces cerevisiae.
K. Fortney, W. Xie, M. Kotlyar, J. Griesman, Y. Kotseruba, and I. Jurisica (2013)
Nucleic Acids Res.
41, D720-D727
|Abstract »|Full Text »|PDF »
Unassembled CD147 is an endogenous endoplasmic reticulum-associated degradation substrate.
R. E. Tyler, M. M. P. Pearce, T. A. Shaler, J. A. Olzmann, E. J. Greenblatt, and R. R. Kopito (2012)
Mol. Biol. Cell
23, 4668-4678
|Abstract »|Full Text »|PDF »
HIF-1{alpha}-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism.
L. Fu, L. Chen, J. Yang, T. Ye, Y. Chen, and J. Fang (2012)
Carcinogenesis
33, 1664-1673
|Abstract »|Full Text »|PDF »
Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance.
M. P. Alcolea, P. Casado, J.-C. Rodriguez-Prados, B. Vanhaesebroeck, and P. R. Cutillas (2012)
Mol. Cell. Proteomics
11, 453-466
|Abstract »|Full Text »|PDF »
Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential.
N. L. Solimini, Q. Xu, C. H. Mermel, A. C. Liang, M. R. Schlabach, J. Luo, A. E. Burrows, A. N. Anselmo, A. L. Bredemeyer, M. Z. Li, et al. (2012)
Science
337, 104-109
|Abstract »|Full Text »|PDF »
The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation.
S. Chen, J. Ma, F. Wu, L.-j. Xiong, H. Ma, W. Xu, R. Lv, X. Li, J. Villen, S. P. Gygi, et al. (2012)
Genes & Dev.
26, 1364-1375
|Abstract »|Full Text »|PDF »
MicroSCALE Screening Reveals Genetic Modifiers of Therapeutic Response in Melanoma.
K. C. Wood, D. J. Konieczkowski, C. M. Johannessen, J. S. Boehm, P. Tamayo, O. B. Botvinnik, J. P. Mesirov, W. C. Hahn, D. E. Root, L. A. Garraway, et al. (2012)
Science Signaling
5, rs4
|Abstract »|Full Text »|PDF »
A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in {beta}2-adrenergic receptor internalization and down-regulation.
X. Jiang, H. Pan, J. F. Nabhan, R. Krishnan, C. Koziol-White, R. A. Panettieri, and Q. Lu (2012)
FASEB J
26, 1995-2007
|Abstract »|Full Text »|PDF »
A primer on using pooled shRNA libraries for functional genomic screens.
Development of Methods for Quantitative Comparison of Pooled shRNAs by Mass Sequencing.
H. Hoshiyama, J. Tang, K. Batten, G. Xiao, J.-M. Rouillard, J. W. Shay, Y. Xie, and W. E. Wright (2012)
J Biomol Screen
17, 258-265
|Abstract »|Full Text »|PDF »
Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells.
R. Marcotte, K. R. Brown, F. Suarez, A. Sayad, K. Karamboulas, P. M. Krzyzanowski, F. Sircoulomb, M. Medrano, Y. Fedyshyn, J. L. Y. Koh, et al. (2012)
Cancer Discovery
2, 172-189
|Abstract »|Full Text »|PDF »
canSAR: an integrated cancer public translational research and drug discovery resource.
M. D. Halling-Brown, K. C. Bulusu, M. Patel, J. E. Tym, and B. Al-Lazikani (2012)
Nucleic Acids Res.
40, D947-D956
|Abstract »|Full Text »|PDF »
COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines.
J. L. Y. Koh, K. R. Brown, A. Sayad, D. Kasimer, T. Ketela, and J. Moffat (2012)
Nucleic Acids Res.
40, D957-D963
|Abstract »|Full Text »|PDF »
A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer.
N. Li, S. Kaur, J. Greshock, H. Lassus, X. Zhong, Y. Wang, A. Leminen, Z. Shao, X. Hu, S. Liang, et al. (2012)
Cancer Res.
72, 154-164
|Abstract »|Full Text »|PDF »
15.16 Cancers of the gastrointestinal tract.
J. A. Bridgewater and S. P. Pereira (2011)
OTM
5, med-9780199204854-chapter
|Abstract »|Full Text »
Mammalian meiosis is more conserved by sex than by species: conserved co-expression networks of meiotic prophase.
A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis.
N. Dompe, C. S. Rivers, L. Li, S. Cordes, M. Schwickart, E. A. Punnoose, L. Amler, S. Seshagiri, J. Tang, Z. Modrusan, et al. (2011)
PNAS
108, E943-E951
|Abstract »|Full Text »|PDF »
Functional Viability Profiles of Breast Cancer.
R. Brough, J. R. Frankum, D. Sims, A. Mackay, A. M. Mendes-Pereira, I. Bajrami, S. Costa-Cabral, R. Rafiq, A. S. Ahmad, M. A. Cerone, et al. (2011)
Cancer Discovery
1, 260-273
|Abstract »|Full Text »|PDF »
Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets.
Y. Ding, D. Huang, Z. Zhang, J. Smith, D. Petillo, B. D. Looyenga, K. Feenstra, J. P. MacKeigan, K. A. Furge, and B. T. Teh (2011)
Cancer Res.
71, 5225-5234
|Abstract »|Full Text »|PDF »
RNA interference in mammals: behind the screen.
E. Campeau and S. Gobeil (2011)
Briefings in Functional Genomics
10, 215-226
|Abstract »|Full Text »|PDF »
Combined Functional Genome Survey of Therapeutic Targets for Clear Cell Carcinoma of the Kidney.
H. Ito, K. Honda, R. Satow, E. Arai, M. Shitashige, M. Ono, T. Sakuma, S. Sakano, K. Naito, H. Matsuyama, et al. (2011)
Jpn. J. Clin. Oncol.
41, 847-853
|Abstract »|Full Text »|PDF »
Prioritizing candidate disease genes by network-based boosting of genome-wide association data.
I. Lee, U. M. Blom, P. I. Wang, J. E. Shim, and E. M. Marcotte (2011)
Genome Res.
21, 1109-1121
|Abstract »|Full Text »|PDF »
Large Scale RNAi Screen Reveals That the Inhibitor of DNA Binding 2 (ID2) Protein Is Repressed by p53 Family Member p63 and Functions in Human Keratinocyte Differentiation.
N. Wu, D. Castel, M.-A. Debily, M. A. Vigano, O. Alibert, R. Mantovani, K. Iljin, P.-H. Romeo, and X. Gidrol (2011)
J. Biol. Chem.
286, 20870-20879
|Abstract »|Full Text »|PDF »
NBA1/MERIT40 and BRE Interaction Is Required for the Integrity of Two Distinct Deubiquitinating Enzyme BRCC36-containing Complexes.
X. Hu, J. A. Kim, A. Castillo, M. Huang, J. Liu, and B. Wang (2011)
J. Biol. Chem.
286, 11734-11745
|Abstract »|Full Text »|PDF »
Making sense of cancer genomic data.
L. Chin, W. C. Hahn, G. Getz, and M. Meyerson (2011)
Genes & Dev.
25, 534-555
|Abstract »|Full Text »|PDF »
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.
K. L. Meerbrey, G. Hu, J. D. Kessler, K. Roarty, M. Z. Li, J. E. Fang, J. I. Herschkowitz, A. E. Burrows, A. Ciccia, T. Sun, et al. (2011)
PNAS
108, 3665-3670
|Abstract »|Full Text »|PDF »
RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase Is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins.
L. Jia, J. S. Bickel, J. Wu, M. A. Morgan, H. Li, J. Yang, X. Yu, R. C. Chan, and Y. Sun (2011)
J. Biol. Chem.
286, 3379-3386
|Abstract »|Full Text »|PDF »
From Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and Beyond.
Mouse models of cancer as biological filters for complex genomic data.
E. Oricchio, A. L. Wolfe, J. H. Schatz, K. J. Mavrakis, and H.-G. Wendel (2010)
Dis. Model. Mech.
3, 701-704
|Abstract »|Full Text »|PDF »
A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.
K. E. Hurov, C. Cotta-Ramusino, and S. J. Elledge (2010)
Genes & Dev.
24, 1939-1950
|Abstract »|Full Text »|PDF »
Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.
A. E. Burrows, A. Smogorzewska, and S. J. Elledge (2010)
PNAS
107, 14280-14285
|Abstract »|Full Text »|PDF »
Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs.
M. Izumiya, K. Okamoto, N. Tsuchiya, and H. Nakagama (2010)
Carcinogenesis
31, 1354-1359
|Abstract »|Full Text »|PDF »
Using Functional Genetics to Understand Breast Cancer Biology.
A. Ashworth and R. Bernards (2010)
Cold Spring Harb Perspect Biol
2, a003327
|Abstract »|Full Text »|PDF »
Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression.
Y. Wang, J. A. Kelber, H. S. T. Cao, G. T. Cantin, R. Lin, W. Wang, S. Kaushal, J. M. Bristow, T. S. Edgington, R. M. Hoffman, et al. (2010)
PNAS
107, 10920-10925
|Abstract »|Full Text »|PDF »
Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma.
R. Satow, M. Shitashige, Y. Kanai, F. Takeshita, H. Ojima, T. Jigami, K. Honda, T. Kosuge, T. Ochiya, S. Hirohashi, et al. (2010)
Clin. Cancer Res.
16, 2518-2528
|Abstract »|Full Text »|PDF »
Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing.
M. Shtutman, A. Maliyekkel, Y. Shao, C. S. Carmack, M. Baig, N. Warholic, K. Cole, E. V. Broude, T. T. Harkins, Y. Ding, et al. (2010)
PNAS
107, 7377-7382
|Abstract »|Full Text »|PDF »
Predicting Meiotic Pathways in Human Fetal Oogenesis.
P. Zheng, M. D. Griswold, T. J. Hassold, P. A. Hunt, C. L. Small, and P. Ye (2010)
Biol Reprod
82, 543-551
|Abstract »|Full Text »|PDF »
Basis for the Isoform-specific Interaction of Myosin Phosphatase Subunits Protein Phosphatase 1c {beta} and Myosin Phosphatase Targeting Subunit 1.
E. Scotto-Lavino, M. Garcia-Diaz, G. Du, and M. A. Frohman (2010)
J. Biol. Chem.
285, 6419-6424
|Abstract »|Full Text »|PDF »
Quantitative cell array screening to identify regulators of gene expression.
The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1.
Y. J. Machida, Y. Machida, A. A. Vashisht, J. A. Wohlschlegel, and A. Dutta (2009)
J. Biol. Chem.
284, 34179-34188
|Abstract »|Full Text »|PDF »
Identification of GAS1 as an Epirubicin Resistance-related Gene in Human Gastric Cancer Cells with a Partially Randomized Small Interfering RNA Library.
L. Zhao, Y. Pan, Y. Gang, H. Wang, H. Jin, J. Tie, L. Xia, Y. Zhang, L. He, L. Yao, et al. (2009)
J. Biol. Chem.
284, 26273-26285
|Abstract »|Full Text »|PDF »
Candidate Biomarkers of Response to an Experimental Cancer Drug Identified through a Large-scale RNA Interference Genetic Screen.
J. Mullenders, W. von der Saal, M. M.W. van Dongen, U. Reiff, R. van Willigen, R. L. Beijersbergen, G. Tiefenthaler, C. Klein, and R. Bernards (2009)
Clin. Cancer Res.
15, 5811-5819
|Abstract »|Full Text »|PDF »
ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence.
NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.
B. Wang, K. Hurov, K. Hofmann, and S. J. Elledge (2009)
Genes & Dev.
23, 729-739
|Abstract »|Full Text »|PDF »
SUMO-Specific Protease 1 (SENP1) Reverses the Hormone-Augmented SUMOylation of Androgen Receptor and Modulates Gene Responses in Prostate Cancer Cells.
S. Kaikkonen, T. Jaaskelainen, U. Karvonen, M. M. Rytinki, H. Makkonen, D. Gioeli, B. M. Paschal, and J. J. Palvimo (2009)
Mol. Endocrinol.
23, 292-307
|Abstract »|Full Text »|PDF »
Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex.
I. P. Trougakos, M. Lourda, M. H. Antonelou, D. Kletsas, V. G. Gorgoulis, I. S. Papassideri, Y. Zou, L. H. Margaritis, D. A. Boothman, and E. S. Gonos (2009)
Clin. Cancer Res.
15, 48-59
|Abstract »|Full Text »|PDF »
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets.
J. M. Flanagan, J. M. Funes, S. Henderson, L. Wild, N. Carey, and C. Boshoff (2009)
Mol. Cancer Ther.
8, 249-260
|Abstract »|Full Text »|PDF »
Highly parallel identification of essential genes in cancer cells.
B. Luo, H. W. Cheung, A. Subramanian, T. Sharifnia, M. Okamoto, X. Yang, G. Hinkle, J. S. Boehm, R. Beroukhim, B. A. Weir, et al. (2008)
PNAS
105, 20380-20385
|Abstract »|Full Text »|PDF »
Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines.
D. A. Grueneberg, W. Li, J. E. Davies, J. Sawyer, J. Pearlberg, and E. Harlow (2008)
PNAS
105, 16490-16495
|Abstract »|Full Text »|PDF »
Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening.
J. M. Silva, K. Marran, J. S. Parker, J. Silva, M. Golding, M. R. Schlabach, S. J. Elledge, G. J. Hannon, and K. Chang (2008)
Science
319, 617-620
|Abstract »|Full Text »|PDF »